IndraLab
Statements
rlimsp
"The most well-defined regulatory mechanism is by phosphorylation of serine-9 in GSK-3β or serine-21 in GSK-3α, which inhibits GSK-3 activity [20-22]. The Akt signaling pathway often is a major regulator of GSK-3 because Akt phosphorylates GSK-3 on these inhibitory serine residues, which has been shown to involved in dopamine signaling and many aspects of psychiatric disorders [23]."
rlimsp
"Leptin stimulation of rat arcuate
increases PKB phosphorylation with subsequent GSK3 phosphorylation at
Ser-9/Ser-21 (13), actions
also reported for leptin on mouse skeletal muscle cells
(32,
33), mouse cortical neurons
(34), and MCF-7 breast cancer
cells (35). These latter
actions of leptin replicate those of insulin, which increases PI3K activity
and raises PtdIns(3,4,5)P3 levels with subsequent increased PKB and
GSK3 phosphorylation (5). Importantly, the phosphorylation of GSK3 at these serine residues by PKB is
associated with reduced kinase activity
(36,
37)."
reach
"More recently, GSK3 was shown to enhance proteasomal degradation of VEGFR-2 by regulating the binding of β-transducin repeats containing E3 ubiquitin protein ligase to VEGFR-2 (29), and GSK3 activity is inhibited by AKT that phosphorylates the serine residues Ser21 in GSK3α and Ser9 in GSK3β (30)."
reach
"For instance, two pancreatic cancer cell lines, PANC1 and ASPC1, exhibit amplification of AKT and high levels of AKT RNA and protein [XREF_BIBR] but also highly active GSK-3beta suggesting that, although some pools of GSK-3 can be phosphorylated by AKT at Ser21 and Ser9 and inhibited, other pools of GSK-3 may remain active in cancer cells [XREF_BIBR]."
rlimsp
"For instance, two pancreatic cancer cell lines, PANC1 and ASPC1, exhibit amplification of AKT and high levels of AKT RNA and protein [43] but also highly active GSK-3β suggesting that, although some pools of GSK-3 can be phosphorylated by AKT at Ser21/Ser9 and inhibited, other pools of GSK-3 may remain active in cancer cells [31]."
rlimsp
"Additionally, Akt phosphorylation inhibits the two isoforms of GSK3 in response to growth factors and hormones, including BDNF, IGF, and insulin (Yamada et al., 2002; Altar et al., 2008). Specifically, Akt phosphorylates specific residues serine 21 for GSK3α and serine 9 for GSK3β that are located in the N-terminal domains of both GSK3 isoforms (Stambolic and Woodgett, 1994; Frame and Cohen, 2001)."
reach
"Li is a monovalent cation that is capable of inhibiting GSK3 both directly, via competition with its cofactor magnesium, and indirectly, via activation of the PI3K/Akt pathway, which phosphorylates GSK3 at the Ser 21 (GSK3α) and Ser 9 (GSK3β) sites, preventing substrate binding to the GSK3 isoforms (Hamstra, Whitley, et al., 2020)."